125 related articles for article (PubMed ID: 28256937)
1. Medical Therapies for Endometriosis Differentially Inhibit Stem Cell Recruitment.
Ersoy GS; Zolbin MM; Cosar E; Mamillapalli R; Taylor HS
Reprod Sci; 2017 Jun; 24(6):818-823. PubMed ID: 28256937
[TBL] [Abstract][Full Text] [Related]
2. Theranekron for treatment of endometriosis in a rat model compared with medroxyprogesterone acetate and leuprolide acetate.
Dolapcioglu K; Dogruer G; Ozsoy S; Ergun Y; Ciftci S; Soylu Karapinar O; Aslan E
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):206-10. PubMed ID: 23827690
[TBL] [Abstract][Full Text] [Related]
3. Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment.
Sakr S; Naqvi H; Komm B; Taylor HS
Endocrinology; 2014 Apr; 155(4):1489-97. PubMed ID: 24484171
[TBL] [Abstract][Full Text] [Related]
4. Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models.
Palmer SS; Altan M; Denis D; Tos EG; Gotteland JP; Osteen KG; Bruner-Tran KL; Nataraja SG
Reprod Sci; 2016 Jan; 23(1):11-23. PubMed ID: 26335175
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.
Crosignani PG; Luciano A; Ray A; Bergqvist A
Hum Reprod; 2006 Jan; 21(1):248-56. PubMed ID: 16176939
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
[TBL] [Abstract][Full Text] [Related]
7. Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
Tabatabaie A; Karimi Zarchi M; Dehghani-Tafti M; Miratashi-Yazdi A; Teimoori S; Dehghani A
Eur J Gynaecol Oncol; 2013; 34(6):552-5. PubMed ID: 24601050
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking.
Pluchino N; Mamillapalli R; Shaikh S; Habata S; Tal A; Gaye M; Taylor HS
J Cell Mol Med; 2020 Feb; 24(4):2464-2474. PubMed ID: 31904910
[TBL] [Abstract][Full Text] [Related]
9. Differential micro ribonucleic acid expression profiling in ovarian endometrioma with leuprolide acetate treatment.
Kiba A; Banno K; Yanokura M; Asada M; Nakayama Y; Aoki D; Watanabe T
J Obstet Gynaecol Res; 2016 Dec; 42(12):1734-1743. PubMed ID: 27709720
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative hormone (endocrine) therapy in endometrial carcinoma].
Hiura M; Oshita T; Nogawa T; Yokoyama T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():381-5. PubMed ID: 15535272
[No Abstract] [Full Text] [Related]
11. Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study.
Grow DR; Williams RF; Hsiu JG; Hodgen GD
J Clin Endocrinol Metab; 1996 May; 81(5):1933-9. PubMed ID: 8626860
[TBL] [Abstract][Full Text] [Related]
12. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.
Mezrow G; Shoupe D; Spicer D; Lobo R; Leung B; Pike M
Fertil Steril; 1994 Nov; 62(5):932-7. PubMed ID: 7926137
[TBL] [Abstract][Full Text] [Related]
13. Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial.
Ferrero S; Venturini PL; Gillott DJ; Remorgida V
Reprod Biol Endocrinol; 2011 Jun; 9():88. PubMed ID: 21693037
[TBL] [Abstract][Full Text] [Related]
14. The effects of letrozole and melatonin on surgically induced endometriosis in a rat model: a preliminary study.
Yildirim G; Attar R; Ozkan F; Kumbak B; Ficicioglu C; Yesildaglar N
Fertil Steril; 2010 Apr; 93(6):1787-92. PubMed ID: 19878935
[TBL] [Abstract][Full Text] [Related]
15. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
Surrey ES; Judd HL
J Clin Endocrinol Metab; 1992 Aug; 75(2):558-63. PubMed ID: 1386374
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis.
Irahara M; Uemura H; Yasui T; Kinoshita H; Yamada M; Tezuka M; Kiyokawa M; Kamada M; Aono T
Gynecol Obstet Invest; 2001; 52(4):217-22. PubMed ID: 11729332
[TBL] [Abstract][Full Text] [Related]
17. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
[TBL] [Abstract][Full Text] [Related]
18. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis.
Zhao Y; Gong P; Chen Y; Nwachukwu JC; Srinivasan S; Ko C; Bagchi MK; Taylor RN; Korach KS; Nettles KW; Katzenellenbogen JA; Katzenellenbogen BS
Sci Transl Med; 2015 Jan; 7(271):271ra9. PubMed ID: 25609169
[TBL] [Abstract][Full Text] [Related]
19. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain.
Friedman AJ; Hornstein MD
Fertil Steril; 1993 Aug; 60(2):236-41. PubMed ID: 8339817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
